May 15 (Reuters) - About 20 deaths linked to serious liver dysfunction have been reported in Japan in patients treated with ...

Twenty people died in Japan after receiving Tavneos, a rare disorder therapy developed by Amgen (AMGN), prompting its local partner Kissei (KSPHF) to urge healthcare professionals to exercise caution ...

Kissei Pharmaceutical, which sells the rare immune-disease drug in Japan, warned doctors to stop prescribing it to new ...

The latest fair value estimate for Amgen has shifted slightly, from US$350.03 to US$349.66, keeping modeled upside closely ...

If you are wondering whether Amgen’s current share price reflects its true worth, starting with a clear look at what the ...

Feb 3 (Reuters) - Amgen on Tuesday reported fourth-quarter financial ‌results that came in ahead of Wall Street ‌expectations, sending its shares modestly higher as the company continues to express ...

New guidelines from two leading medical associations suggest that efforts to reduce bad cholesterol should focus on ...

NEW ALBANY, Ohio — Biotechnology company Amgen announced a $900 million expansion of its New Albany facility on Friday. The expansion will add 350 new jobs in central Ohio. Several leaders spoke at an ...

Guggenheim trimmed its price target (PT) on Amgen (NASDAQ:AMGN | AMGN Price Prediction) to $340 from $351 on Monday, May 4, ...

Amgen announced 52-week results from a phase 2 trial with its weight-management candidate, MariTide. The results Amgen posted don't appear very competitive with Eli Lilly's weight management drug, ...

About 20 deaths linked to serious liver dysfunction have been reported in Japan in patients treated with Amgen's rare disease ...